Related Experiment Video
Updated: Dec 31, 2025

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Body Mass Index and Major Adverse Cardiovascular Events: A Secondary Analysis Based on a Retrospective Cohort Study
1The Affiliated Hospital of Weifang Medical College, Shandong, China (mainland).
Insights
Overweight patients with stable coronary artery disease (CAD) have a lower risk of major adverse cardiovascular events (MACE) after percutaneous coronary intervention (PCI). The optimal body mass index (BMI) threshold for predicting MACE is 24.23 kg/m².
Area of Science:
- Cardiology
- Metabolic Health
- Clinical Research
Background:
- The relationship between Body Mass Index (BMI) and Major Adverse Cardiovascular Events (MACE) in patients with stable Coronary Artery Disease (CAD) remains controversial.
- Existing research lacks clarity on whether different BMI categories influence cardiovascular outcomes post-intervention.
Purpose of the Study:
- To investigate the association between BMI and MACE in patients with stable CAD undergoing elective Percutaneous Coronary Intervention (PCI).
- To determine if BMI influences cardiovascular event risk following PCI.
Main Methods:
- Secondary analysis of a retrospective cohort study involving 204 patients with stable CAD.
- Patients were categorized into underweight (BMI <18.5 kg/m²), normal BMI (18.5–24.9 kg/m²), and overweight (BMI ≥25 kg/m²).
- Primary endpoint was MACE, with follow-up for a median of 783 days.
Main Results:
- Overweight patients (BMI ≥25 kg/m²) exhibited significantly fewer MACE compared to normal BMI individuals (OR=0.17; 95% CI: 0.03–0.84).
- No significant difference in MACE was observed between underweight and normal BMI groups (OR=1.73; 95% CI: 0.42–7.17).
- BMI positively correlated with hemoglobin and albumin, and negatively with HDL cholesterol. The optimal BMI threshold for MACE prediction was 24.23 kg/m² (AUC=0.729).
Conclusions:
- Overweight status in stable CAD patients is associated with a reduced risk of MACE after PCI.
- An optimal BMI threshold of 24.23 kg/m² can aid in predicting MACE in this patient population.
Abstract:
BACKGROUND The association between body mass index (BMI) and major adverse cardiovascular events (MACE) has not been clarified and is controversial. Therefore, the purpose of present study is to explore the association between BMI and MACE. MATERIAL AND METHODS This was a secondary analysis of a retrospective cohort study in which 204 participants who were diagnosed with stable coronary artery disease (CAD) and received elective percutaneous coronary intervention (PCI) were recruited. According to the BMI, patients were divided into 3 categories - underweight (BMI <18.5 kg/m²), normal BMI (18.5 ≤BMI <25 kg/m²), and overweight (BMI ≥25 kg/m²)], and the patients were followed up. The primary endpoint was MACE. RESULTS After a median follow-up of 783 days, MACE events had occurred in 18 participants. After controlling for potential confounding factors, no difference was observed in MACE between the underweight group and the normal BMI group (OR=1.73, 95% CI 0.42 to 7.17); but there were significantly fewer MACE in the overweight group than in the normal BMI group (OR=0.17; 95% CI: 0.03 to 0.84). Pearson correlation analysis showed that BMI was positively correlated with hemoglobin (r=0.2102) and albumin (r=0.2780), but negatively correlated with high-density lipoprotein cholesterol (r=-0.2052). The receiver operating characteristic curve (ROC) showed that the best threshold for BMI to predict MACE was 24.23, the area under the curve was 0.729, sensitivity was 0.893, and the specificity was 0.460. CONCLUSIONS Our study shows that overweight patient with stable CAD have lower risk of MACE after PCI, and the optimal threshold for predicting MACE is 24.23.
Related Concept Videos
Obesity
Coronary Artery Disease I: Introduction
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Atherosclerosis III: Management
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

